The 21st Century Cures Act, passed by the Senate yesterday with overwhelming bipartisan support, is an important victory for biotechnology and medical innovation that will help expedite the development of the next generation medicines, expediate drug approval process, while helping to lower other healthcare costs. The bill provides for $4.8 billion in new funding for the National Institutes of Health; of that, $1.8 billion is reserved for the “cancer moonshot” launched by Vice President Biden to accelerate research in that field. Another $1.6 billion is earmarked for brain diseases including Alzheimer’s. Also included are $500 million in new funding for the Food and Drug Administration and $1 billion in grants to help states deal with opioid abuse, Washington Post reports. Read full story
Related Posts
University of Maine recruiting homeowners for tick surveys
ORONO, Maine — With tick season upon us, researchers at the University of Maine want to know what Mainers are doing...
Maine’s oldest bioscience symposium turns 50 on MDI
Students and accomplished science leaders share research on Mt. Desert Island This April 20 marked the 50th anniversary meeting of the...
Husson University students, faculty share projects at 13th annual Research Showcase
BANGOR, Maine — Today marked Husson University’s 13th annual Research and Scholarship Day. Students and faculty members at Husson shared the...